US Broker Ratings

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Biotechnology Visionary with a 50% Upside Potential

LENZ Therapeutics, Inc. (NASDAQ: LENZ) stands out in the biotechnology sector, not only for its innovative approach to treating vision impairment but also for its compelling..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: A 318% Upside Potential Awaits Investors

Investors keeping a close eye on the biotechnology sector might find Day One Biopharmaceuticals, Inc (NASDAQ: DAWN) a compelling opportunity. Known for its innovative approach in..

Xencor, Inc. (XNCR)

⚠️ No article content returned.

..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating the Challenges with Growth Potential in Healthcare

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, specializes in providing medical device solutions worldwide. With a market capitalization of $572.04 million,..

HealthStream, Inc. (HSTM) Stock Analysis: Navigating Potential Upside of 25.68%

Investors looking for opportunities in the healthcare technology space should turn their attention to HealthStream, Inc. (NASDAQ: HSTM). As a leader in providing Software-as-a-Service (SaaS) solutions..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Unveiling a Potential 317% Upside in the Biotech Arena

Anavex Life Sciences Corp. (NASDAQ: AVXL), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to treating central nervous system..

Owens & Minor, Inc. (OMI) Stock Analysis: Exploring the 19.20% Potential Upside for Investors

Owens & Minor, Inc. (NYSE: OMI), a longstanding player in the healthcare sector, presents a curious case for investors searching for opportunities amidst market fluctuations. With..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: Exploring a 220% Potential Upside with Strong Buy Ratings

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a key player in the biotechnology sector, is currently capturing the attention of investors with its robust pipeline of cancer therapies..

Akebia Therapeutics, Inc. (AKBA): Investor Outlook with a Promising 102.74% Potential Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a burgeoning player in the healthcare sector, is capturing investor attention with its significant potential upside of 102.74%. Specializing in the..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a Potential 215% Upside in the Biotech Sector

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is capturing the interest of investors with its compelling potential upside of 215.09%, highlighted by a consensus of ten buy..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Navigating a 39% Upside Potential in the Healthcare Sector

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a leader in the specialty pharmaceutical industry, is drawing investor attention with its robust growth metrics and intriguing stock valuation. Positioned..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Strong Revenue Growth with a 5.37% Potential Upside

Niagen Bioscience, Inc. (NAGE) is emerging as a noteworthy player in the biotechnology sector, particularly within the healthcare industry. Headquartered in Los Angeles, California, this U.S.-based..

Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a 14.34% Upside Potential in the Medical Devices Sector

Beta Bionics, Inc. (NASDAQ: BBNX) is a promising player in the healthcare sector, specifically within the medical devices industry. Specializing in innovative solutions for diabetes care,..

Delcath Systems, Inc. (DCTH) Stock Analysis: Unveiling a 53.95% Potential Upside in the Healthcare Sector

Investors with a keen eye for opportunities in the healthcare sector may find Delcath Systems, Inc. (DCTH) particularly intriguing. With a market cap of $544.68 million,..

Akso Health Group (AHG) Stock Analysis: A 676% Revenue Growth Story with a Cautious Investor Outlook

Investors looking to diversify their portfolios with a unique healthcare play might find Akso Health Group (NASDAQ: AHG) an intriguing prospect. With an astounding revenue growth..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a Potential 332.78% Upside in the Biotechnology Sector

Nuvation Bio Inc. (NUVB), a dynamic player in the healthcare sector, specifically in biotechnology, has recently caught the attention of investors due to its promising portfolio..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: A Promising 82% Potential Upside Awaits Investors

Avadel Pharmaceuticals plc (NASDAQ: AVDL), headquartered in Dublin, Ireland, is making waves in the healthcare sector with its promising drug development endeavors. As a specialist in..

iRadimed Corporation (IRMD) Stock Analysis: Uncovering a 19% Potential Upside in the Medical Device Sector

iRadimed Corporation (NASDAQ: IRMD), a key player in the healthcare sector, is capturing investor attention with its robust growth potential and strategic position in the medical..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating Growth in Diagnostics & Research with a 7.99% Potential Upside

Fulgent Genetics, Inc. (NASDAQ: FLGT) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $639.01 million,..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Evaluating a 201% Upside Potential Amidst Clinical Progress

Arcus Biosciences, Inc. (NASDAQ: RCUS) is capturing investor attention with its strong potential for growth in the high-stakes biotechnology sector. Situated in the United States and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds